ICRF Medical Oncology Unit

Oxford, Oxfordshire OX3 7LJ

0 studies enrolling now · 2 studies all time

What they study most

Gastric Adenocarcinoma, Gastroesophageal Adenocarcinoma, Pancreatic Cancer

Studies at this site

• OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer. — Completed
• Phase II Study of Single Agent OSI-7904L in Patients With Gastric or Gastroesophageal (GEJ) Cancer — Completed